摘要
冠心病合并焦虑抑郁的发病率逐年升高,但是识别率和诊治率较低。目前西医认为其发病机制可能与炎症反应、神经内分泌学说、血小板活化、内皮损伤等相关;中医认为气血阴阳亏损以及气滞、血瘀、痰浊为主要病因病机。治疗方式主要是在冠心病二级预防的基础上,联合中西医药物及非药物治疗焦虑抑郁,有效控制其危险因素。现主要对冠心病合并焦虑抑郁的发病机制及治疗进展进行报道。
The morbidity of coronary heart disease with anxiety and depression increases year by year,but its recognition rate and diagnosis and treatment rate are low.At present,western medicine believes that the pathogenesis of coronary heart disease with anxiety and depression may be related to inflammatory reaction,neuroendocrine system,platelet activation,endothelial injury,etc.,while traditional Chinese Medicine(TCM)holds that the deficiency of Qi,blood,Yin and Yang,Qi stagnation,blood stasis,turbid phlegm are the main etiology and pathogenesis.The treatment is mainly based on secondary prevention of coronary heart disease,combined with traditional Chinese and western medicine and non-drug treatment of anxiety and depression,to effectively control the risk factors.This paper reviewed the pathogenesis and treatment of coronary heart disease with anxiety and depression.
作者
史金玉
王超
黄乐曦
赵海滨
SHI Jinyu;WANG Chao;HUANG Lexi;ZHAO Haibin(Beijing University of Chinese Medicine,Beijing 100029,China;Dongfang Hospital of Beijing University of Chinese Medicine,Beijing 100078,China)
出处
《世界中医药》
CAS
2022年第14期2087-2091,共5页
World Chinese Medicine
基金
首都临床特色应用研究与成果推广项目(Z161100000516136)。
关键词
冠心病
焦虑
抑郁
发病机制
治疗方式
Coronary heart disease
Anxiety
Depression
Pathogenesis
Treatment
